Regulation of intestinal development by a Lactobacillus GG-derived protein
乳杆菌 GG 衍生蛋白对肠道发育的调节
基本信息
- 批准号:9269404
- 负责人:
- 金额:$ 39.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultApoptosisBiological AssayBiological PreservationCell LineCell ProliferationChildClinicalColitisColonDTR geneDataDevelopmentDiseaseDisintegrinsEpidermal Growth Factor ReceptorEpithelialEpithelial Cell ProliferationEpithelial CellsGastrointestinal tract structureGenesGrowthHealthHumanHydrogelsImmuneImmune systemImmunocompromised HostIndividualInflammationInjuryInterleukin-9InterruptionIntestinesKnowledgeLactobacillusLactobacillus casei rhamnosusLifeLigandsMediatingMetalloproteasesMucinsMusNatureNeonatalNutrientNutritionalOrgan Culture TechniquesPectinsPersonsPhysiologicalPhysiological ProcessesPlayPredispositionProbioticsProductionProteinsPublishingReceptor ActivationReceptor SignalingRegulationResearchRoleSignal PathwaySignal TransductionSmall Interfering RNAStagingSystemTestingTight JunctionsTissuesTranscriptional RegulationUp-RegulationVillusWeaningWeight GainWorkZeinbaseclinical applicationclinical efficacycytokinedisorder preventionfetalgut microbiotaintestinal epitheliummigrationmouse modelnutrient metabolismorgan growthpostnatalpreventresearch studyresponsetissue culturetranscriptomeuptake
项目摘要
DESCRIPTION (provided by applicant): The symbiotic relationship between intestinal microbiota and the host plays an important role in the intestinal development. Interruption of this
relationship leads to infectious and immune-mediated diseases. This underscores the importance of identifying the effects of probiotics on intestinal development and disease prevention in children. However, there are critical gaps in knowledge about mechanisms of probiotic action. The efficacy of probiotics for nutritional and clinical application remains to be
convincingly established. p40, a LGG-derived protein isolated and cloned by our group, activates epidermal growth factor receptor (EGFR) and its downstream target, PI3K/Akt in intestinal epithelial cells through stimulation of EGFR ligand release. Activation of EGFR by p40 is required for inhibition of cytokine-induced apoptosis, preservation of barrier function, and enhancement of mucin production in intestinal epithelial cells. We have generated a pectin/zein hydrogel bead system to specifically delivered p40 to the colon in mouse. By using this delivery system p40 has been sown to prevent and treat experimental colitis in mice in an EGFR-dependent manner. Since activation of EGFR plays a physiological role in development, we have expanded the scope of our work to investigate the effects of p40 on intestinal development. Based on our preliminary results that LGG colonization promotes functional maturation of the intestine and decreases susceptibility to intestinal injury and colitis in adult mice, three integrated specific aims are proposed to enhance knowledge of the functional nature of p40 in regulation of intestinal development and mechanisms of the action of p40. In Specific Aim 1, the roles of p40 in intestinal functional maturation will be determined. We will use neonatal mice, human fetal intestinal organ culture, and human and mouse enteroids to determine the roles of p40 in intestinal epithelial cell proliferation, differentiation, migration,and digestive and absorptive capacities and epithelial tight junction formation. In Specific Aim 2, transcriptional targets in intestinal epithelial cells involved in p40-regulated cellular responsesto promote intestinal functional maturation will be defined. We will determine p40-regulated intestinal epithelial genes in neonatal mice and in human fetal intestinal organ culture, and verif the function of individual candidate p40-regulated genes predicted to regulate epithelial proliferation, differentiation, migration, transporters, and tight junction formation using in vitr and ex vivo assays. In Specific Aim 3, the p40- stimulated signaling pathway in intestinal epithelial cells that is required for promotion of intestinal functional maturation will be elucidaed. We will use mouse models with intestinal epithelial cell-specific deficiency of EGFR and PI3K and pharmacologic inhibition of EGFR and Akt in human fetal intestinal organ culture and enteroids to determine the requirement of EGFR and Akt activation for p40-stimulated epithelial responses and p40-regulated EGFR and Akt-dependent transcriptional targets for functional maturation. These studies will contribute new information for nutritional and clinical applications
of p40 for health in children.
描述(由申请人提供):肠道微生物群与宿主之间的共生关系在肠道发育的中断中发挥着重要作用。
这强调了确定益生菌对儿童肠道发育和疾病预防的影响的重要性,然而,关于益生菌作用机制的了解还存在重大差距。临床应用仍有待
p40 是我们小组分离和克隆的 LGG 衍生蛋白,通过刺激 EGFR 配体释放来激活表皮生长因子受体 (EGFR) 及其下游靶标 PI3K/Akt。抑制细胞因子诱导的细胞凋亡、保护屏障功能和增强肠上皮细胞中粘蛋白的产生所需的我们已经产生了果胶/玉米醇溶蛋白水凝胶珠。系统将 p40 特异性递送至小鼠结肠。通过使用该递送系统,p40 已被用于以 EGFR 依赖性方式预防和治疗小鼠实验性结肠炎。由于 EGFR 的激活在发育中发挥生理作用,因此我们扩展了该系统。我们的工作范围是研究 p40 对肠道发育的影响,基于 LGG 定植促进成年小鼠肠道功能成熟并降低对肠道损伤和结肠炎的易感性的初步结果,我们的三个综合具体目标是。建议加强对 p40 在肠道发育调节中的功能性质和 p40 作用机制的了解。在具体目标 1 中,我们将使用新生小鼠、人类胎儿肠道器官来确定 p40 在肠道功能成熟中的作用。培养物以及人和小鼠肠样,以确定 p40 在肠上皮细胞增殖、分化、迁移、消化和吸收能力以及上皮紧密连接形成中的作用。我们将确定新生小鼠和人胎儿肠道器官培养物中参与 p40 调节的细胞反应的肠上皮细胞,并验证预测的单个候选 p40 调节基因的功能。使用体外和离体试验调节上皮增殖、分化、迁移、转运蛋白和紧密连接形成。在特定目标 3 中,肠上皮细胞中 p40 刺激的信号通路。我们将利用肠上皮细胞特异性缺乏 EGFR 和 PI3K 的小鼠模型以及人胎儿肠道器官培养物和肠样中 EGFR 和 Akt 的药理抑制来阐明促进肠道功能成熟所需的物质。 p40 刺激的上皮反应的 Akt 激活以及 p40 调节的 EGFR 和 Akt 依赖性转录靶点的功能成熟这些研究将为营养和临床提供新的信息。应用
p40 有益于儿童健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FANG YAN其他文献
FANG YAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FANG YAN', 18)}}的其他基金
A probiotic-derived protein regulates epigenetic programming in intestinal epithelial cells for long-term prevention of colitis
益生菌衍生的蛋白质调节肠上皮细胞的表观遗传编程,以长期预防结肠炎
- 批准号:
10386935 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Probiotics-derived soluble proteins regulate intestinal inflammation
益生菌衍生的可溶性蛋白质调节肠道炎症
- 批准号:
8586657 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Probiotics-derived soluble proteins regulate intestinal inflammation
益生菌衍生的可溶性蛋白质调节肠道炎症
- 批准号:
8440768 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Regulation of intestinal development by a Lactobacillus GG-derived protein
乳杆菌 GG 衍生蛋白对肠道发育的调节
- 批准号:
9256458 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Probiotics-derived soluble proteins regulate intestinal inflammation
益生菌衍生的可溶性蛋白质调节肠道炎症
- 批准号:
7582872 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
A probiotic-derived protein regulates epigenetic programming in intestinal epithelial cells for long-term prevention of colitis
益生菌衍生的蛋白质调节肠上皮细胞的表观遗传编程,以长期预防结肠炎
- 批准号:
10598497 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Regulation of intestinal development by a Lactobacillus GG-derived protein
乳杆菌 GG 衍生蛋白对肠道发育的调节
- 批准号:
8964588 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Probiotics-derived soluble proteins regulate intestinal inflammation
益生菌衍生的可溶性蛋白质调节肠道炎症
- 批准号:
7759167 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
Probiotics-derived soluble proteins regulate intestinal inflammation
益生菌衍生的可溶性蛋白质调节肠道炎症
- 批准号:
8055059 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
A probiotic-derived protein regulates epigenetic programming in intestinal epithelial cells for long-term prevention of colitis
益生菌衍生的蛋白质调节肠上皮细胞的表观遗传编程,以长期预防结肠炎
- 批准号:
10160874 - 财政年份:2009
- 资助金额:
$ 39.5万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 39.5万 - 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:
10679988 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
A Gene-Network Discovery Approach to Structural Brain Disorders
结构性脑疾病的基因网络发现方法
- 批准号:
10734863 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Plasma neurofilament light chain as a potential disease monitoring biomarker in Wolfram syndrome
血浆神经丝轻链作为 Wolfram 综合征潜在疾病监测生物标志物
- 批准号:
10727328 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 39.5万 - 项目类别: